COMMUNIQUÉS West-GlobeNewswire

Collegium Pharmaceutical and Boston Legacy FC Expand Their Partnership Beyond Matchday to Communities Across Massachusetts
29/10/2026
New multi-year partnership combines youth coach training, an annual Sports for All Summit, and sensory inclusion programs to support neurodivergent children and families STOUGHTON, Mass., Oct. 29, 2026 (GLOBE NEWSWIRE [...]
Vaxart to Host Stockholder Fireside Chat on November 6 at 4:30 p.m. ET
29/10/2026
Company to report third quarter 2026 financial results on November 5 SOUTH SAN FRANCISCO, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range [...]
Intellia Therapeutics Announces Upcoming Lonvoguran Ziclumeran (Lonvo-z) Investor Event and Seven Presentations at ACAAI 2026
29/10/2026
Oral presentations to include four-year follow-up data from patients who received a one-time 50 milligram (mg) dose of lonvo-z; insights on new hereditary angioedema (HAE) treatment goals Poster presentations to include [...]
MIRA Pharmaceuticals Reports Significant Weight and Fat Reduction With Oral SKNY-1 in Obese Mice, Showing Favorable Lean-Mass and Weight-Regain Outcomes Compared With Semaglutide
29/10/2026
SKNY-1's Weight Reduction Without Significant Changes in Food Consumption Suggests a Potential Role for Energy Expenditure, Contrasting With Semaglutide's Initial Food-Intake Suppression and Significant Post-Treatment [...]
Processa Pharmaceuticals Announces Corporate and Pipeline Progress Following Acquisition of Vidya Therapeutics
29/10/2026
U.S. FDA clears IND for Phase 2 study of VT-7208 in chronic spontaneous urticaria; additional Phase 2 studies planned in food allergy and relapsing multiple sclerosis Company expands pipeline through research [...]
Oak Hill Bio to Present at Upcoming Investor Conferences
29/10/2026
CAMBRIDGE, Mass., Oct. 29, 2026 (GLOBE NEWSWIRE) -- OHB Pediatrics Ltd d/b/a Oak Hill Bio, a clinical-stage rare disease therapeutics company, today announced that the company will participate in the following investor [...]
Annovis to Participate in U.S. Biotech Day 2026 and Pharma Partnering Summit 2026
29/10/2026
Maria Maccecchini, PhD, CEO of Annovis, will join industry panel with pharma leaders and present company updates MALVERN, Pa., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company [...]
Immutep Quarterly Activities Report Q1 FY27
29/10/2026
Media Release Immutep intends to focus the registration-directed clinical development of efti on HNSCC in patients with CPS <1 and the neoadjuvant setting of STS, with preparations for future clinical trials underway [...]
Breckenridge Distillery and University of Denver Athletics Release Limited-Edition Whiskey Celebrating Record 11th NCAA Men’s Hockey Championship
29/10/2026
$100 from every bottle sold will benefit Denver men’s ice hockey scholarships DENVER, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Breckenridge Distillery , an award-winning craft distillery and subsidiary of Tilray Brands, Inc. ( [...]
SCYNEXIS to Participate in the 3rd Annual Guggenheim Healthcare Innovation Conference
29/10/2026
JERSEY CITY, N.J., Oct. 29, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a clinical-stage biotechnology company dedicated to advancing innovative solutions for severe rare diseases, today announced that the [...]
MediWound to Report Third Quarter 2026 Financial Results
29/10/2026
MediWound to Report Third Quarter 2026 Financial Results Conference Call and Webcast Scheduled for Thursday, November 12 th at 8:30 a.m. Eastern Time YAVNE, Israel, October 29, 2026 -- MediWound Ltd. (Nasdaq: MDWD), a [...]
aTyr Pharma Announces Publication of Results from the Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis in The Lancet Respiratory Medicine
29/10/2026
Peer-reviewed publication reinforces efzofitimod’s differentiated profile and potential to advance pulmonary sarcoidosis care. SAN DIEGO, Oct. 29, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the [...]
20/20 BioLabs to Host November 4 Investor Webinar on OneTest™ Commercial Expansion and Growth Strategy
29/10/2026
CEO Jonathan Cohen to Discuss Laboratory Franchise Model, 2027 Licensing Plans, Potential Acquisitions, FDA Strategy, and Firefighter Cancer Screening Initiatives Webinar to Be Held Wednesday, November 4, 2026 at 12:00 [...]
Painletics Launches App to Help With Stiff Necks and Sore Joints
29/10/2026
Painletics App Turns a Short Quiz Into a Daily Routine for the Neck, Back and Joints NEW YORK, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Painletics has launched a personalized mobility and wellness app built around short guided [...]
INmune Bio Inc. to Report Third Quarter 2026 Financial Results and Provide Corporate Update on Thursday, November 5th
29/10/2026
Management to host conference call and webcast at 4:30 pm ET on that day BOCA RATON, Fla, Oct. 29, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a late-stage biotechnology company focused on [...]
FEM By UPSA Highlights Growing Body of Research on Non-Hormonal Menopause Support, Including Studies in Breast Cancer Survivors
29/10/2026
Decades of research address key considerations for healthcare professionals discussing non-hormonal menopause options with patients RUEIL-MALMAISON, France, Oct. 29, 2026 (GLOBE NEWSWIRE) -- FEM By UPSA is highlighting [...]
Spirited Paw® Pet Supplements Now Available at Chewy
29/10/2026
Launch expands nationwide access to whole food-based nutritional supplements for dogs and cats PALMYRA, Wis., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Standard Process® , a leader in whole food nutrition, today announced that [...]
Mendoza Family Fund Surpasses $1 Million in Partnership with the National Multiple Sclerosis Society
29/10/2026
Milestone marks the culmination of years of grassroots fundraising inspired by the family’s matriarch Elsa Mendoza’s journey with MS NEW YORK, Oct. 29, 2026 (GLOBE NEWSWIRE) -- The Mendoza Family Fund , created in [...]
Tangram Announces First Participant Dosed in Phase 1 Trial of TGM-148, a Novel Investigational RNAi Medicine for Bleeding Disorders
29/10/2026
TGM-148 is designed to combine hemostatic efficacy with a favorable safety profile and low treatment burden Tangram’s second asset to enter the clinic in 2026 Phase 1 trial will evaluate TGM-148 in healthy volunteers, [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum